市場調査レポート
商品コード
1208912

治療用コンタクトレンズの世界市場 - 見通しと予測(2022年~2027年)

Therapeutic Contact Lenses Market - Global Outlook & Forecast 2022-2027

出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 282 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
治療用コンタクトレンズの世界市場 - 見通しと予測(2022年~2027年)
出版日: 2023年02月02日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 282 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の治療用コンタクトレンズの市場規模は、2021年~2027年にCAGRで4.90%の成長が予測されています。眼科疾患の有病率と高齢者人口の増加や、コンタクトレンズ技術の進歩が、市場の成長促進要因となっています。

当レポートでは、世界の治療用コンタクトレンズ市場について調査分析し、市場規模と予測、促進要因、競合情勢などを提供しています。

目次

第1章 調査手法

第2章 調査目的

第3章 調査プロセス

第4章 範囲

第5章 レポートの前提条件と注意事項

第6章 市場の概要

第7章 主要考察

  • 概要

第8章 イントロダクション

  • 概要

第9章 市場機会と動向

第10章 市場の成長促進要因

第11章 市場抑制要因

第12章 市場情勢

  • 市場の概要
  • 市場規模と予測
    • 地域の考察
    • 材料セグメンテーションの考察
    • 使用法セグメンテーションの考察
    • 用途セグメンテーションの考察
    • 流通チャネルセグメンテーションの考察
  • ファイブフォース分析

第13章 材料

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • ソフトコンタクトレンズ
  • ハードコンタクトレンズ

第14章 使用法

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 毎日の交換
  • 頻繁な交換

第15章 用途

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 眼科手術後
  • 角膜手術/障害
  • ドラッグデリバリー
  • その他

第16章 流通チャネル

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • オムニチャネル
  • 病院・眼科クリニック

第17章 地域

  • 市場のスナップショットと成長エンジン
  • 地理的概要

第18章 北米

  • 市場の概要
  • 市場規模と予測
    • 北米市場:北米別
    • 北米市場:北米別
    • 北米の北米市場
    • 北米市場:北米経路別
  • 主要国
    • 米国:市場規模と予測
    • カナダ:市場規模と予測

第19章 アジア太平洋

  • 市場の概要
  • 市場規模と予測
    • アジア太平洋の治療用コンタクトレンズ市場:材料別
    • アジア太平洋の治療用コンタクトレンズ市場:使用法別
    • アジア太平洋の治療用コンタクトレンズ市場:用途別
    • アジア太平洋の治療用コンタクトレンズ市場:流通チャネル別
  • 主要国
    • 日本:市場規模と予測
    • 中国:市場規模と予測
    • インド:市場規模と予測
    • 韓国:市場規模と予測
    • オーストラリア:市場規模と予測

第20章 欧州

  • 市場の概要
  • 市場規模と予測
    • 欧州の治療用コンタクトレンズ市場:材料別
    • 欧州の治療用コンタクトレンズ市場:使用法別
    • 欧州の治療用コンタクトレンズ市場:用途別
    • 欧州の治療用コンタクトレンズ市場:流通チャネル別
  • 主要国
    • ドイツ:市場規模と予測
    • フランス:市場規模と予測
    • 英国:市場規模と予測
    • スペイン:市場規模と予測
    • イタリア:市場規模と予測

第21章 ラテンアメリカ

  • 市場の概要
  • 市場規模と予測
    • ラテンアメリカの治療用コンタクトレンズ市場:材料別
    • ラテンアメリカの治療用コンタクトレンズ市場:使用法別
    • ラテンアメリカの治療用コンタクトレンズ市場:用途別
    • ラテンアメリカの治療用コンタクトレンズ市場:流通チャネル別
  • 主要国
    • ブラジル:市場規模と予測
    • メキシコ:市場規模と予測
    • アルゼンチン:市場規模と予測

第22章 中東・アフリカ

  • 市場の概要
  • 市場規模と予測
    • 中東・アフリカの治療用コンタクトレンズ市場:材料別
    • 中東・アフリカの治療用コンタクトレンズ市場:使用法別
    • 中東・アフリカの治療用コンタクトレンズ市場:用途別
    • 中東・アフリカの治療用コンタクトレンズ市場:流通チャネル別
  • 主要国
    • トルコ:市場規模と予測
    • 南アフリカ:市場規模と予測
    • サウジアラビア:市場規模と予測
    • アラブ首長国連邦:市場規模と予測

第23章 競合情勢

  • 競合の概要
  • 市場シェア分析
    • ALCON
    • BAUSCH & LOMB
    • JOHNSON & JOHNSON
    • THE COOPER COMPANIES

第24章 主要企業プロファイル

  • ALCON
  • BAUSCH & LOMB
  • JOHNSON & JOHNSON
  • THE COOPER COMPANIES

第25章 その他の著名なベンダー

  • ABB OPTICAL GROUP
  • ACCULENS
  • ADVANCED VISION TECHNOLOGIES
  • CONTAMAC
  • EXCELLENT HI-CARE
  • MEDENNIUM
  • MENICON
  • METRO OPTICS
  • ORION VISION GROUP
  • POLYTOUCH
  • ST. SHINE OPTICAL
  • SURGITECH INNOVATION
  • SYNEREYES
  • ULTRAVISION CLPL
  • WALMAN
  • VISIONARY OPTICS

第26章 レポートサマリー

  • 重要事項
  • 戦略的推奨事項

第27章 定量的要約

第28章 付録

図表

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL THERAPEUTIC CONTACT LENSES MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 IMPACT OF INCREASE IN SILICONE HYDROGEL CONTACT LENSES APPLICATION
  • EXHIBIT 4 IMPACT OF ADVANCES IN DRUG-DELIVERY CONTACT LENSES TECHNOLOGY
  • EXHIBIT 5 IMPACT OF INTRODUCTION OF HI- TECH CONTACT LENSES
  • EXHIBIT 6 IMPACT OF GROWING PREVALENCE OF OPHTHALMIC DISORDERS & GERIATRIC POPULATION
  • EXHIBIT 7 IMPACT OF ADVANCES IN CONTACT LENSES TECHNOLOGY
  • EXHIBIT 8 IMPACT OF PUBLIC AND PRIVATE INITIATIVES TO INCREASE VISION CARE AWARENESS
  • EXHIBIT 9 IMPACT OF HIGH COST OF THERAPEUTIC CONTACT LENSES
  • EXHIBIT 10 IMPACT OF ADVERSE EVENTS ASSOCIATED WITH CONTACT LENSES
  • EXHIBIT 11 IMPACT OF LOW ACCESSIBILITY, AFFORDABILITY & FINANCIAL EXCLUSION FOR LARGE PATIENT POOL
  • EXHIBIT 12 NUMBER OF PEOPLE WITH TREATED & UNTREATED VISION IMPAIRMENTS WORLDWIDE (BILLION)
  • EXHIBIT 13 NUMBER OF OPHTHALMOLOGISTS PER MILLION POPULATION 2019
  • EXHIBIT 14 EYE CARE PRACTICES WITNESSING MARKET CHANGES
  • EXHIBIT 15 GLOBAL THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 16 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027 (%)
  • EXHIBIT 17 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL: MARKET SHARE 2021 & 2027 (%)
  • EXHIBIT 18 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE: MARKET SHARE 2021 & 2027 (%)
  • EXHIBIT 19 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION: MARKET SHARE 2021 & 2027 (%)
  • EXHIBIT 20 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL: MARKET SHARE 2021 & 2027 (%)
  • EXHIBIT 21 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 22 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
  • EXHIBIT 23 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL: INCREMENTAL GROWTH
  • EXHIBIT 24 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL: ABSOLUTE GROWTH
  • EXHIBIT 25 GLOBAL SOFT THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 26 GLOBAL SOFT THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 27 GLOBAL RIGID THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 28 GLOBAL RIGID THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 29 INCREMENTAL GROWTH BY USAGE 2021 & 2027
  • EXHIBIT 30 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE: INCREMENTAL GROWTH
  • EXHIBIT 31 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE: ABSOLUTE GROWTH
  • EXHIBIT 32 GLOBAL DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 33 GLOBAL DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 34 GLOBAL FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 35 GLOBAL FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 36 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
  • EXHIBIT 37 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION: INCREMENTAL GROWTH
  • EXHIBIT 38 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION: ABSOLUTE GROWTH
  • EXHIBIT 39 GLOBAL POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 40 GLOBAL POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 41 GLOBAL CORNEAL SURGERY/DISORDERS THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 42 GLOBAL CORNEAL SURGERY/DISORDERS THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 43 GLOBAL DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 45 GLOBAL OTHER THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 46 GLOBAL OTHER THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 47 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
  • EXHIBIT 48 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH
  • EXHIBIT 49 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH
  • EXHIBIT 50 GLOBAL OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 51 GLOBAL OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 52 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY HOSPITAL & EYE CARE CLINICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 53 GLOBAL HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 54 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 55 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 56 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 57 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 58 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
  • EXHIBIT 59 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 60 INCREMENTAL GROWTH BY NORTH AMERICA 2021 & 2027
  • EXHIBIT 61 US POPULATION SUFFERING FROM VISION DISORDERS (MILLION)
  • EXHIBIT 62 US THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 63 CANADA THERAPEUTIC CONTACT LENSES MARKET 2021-2027($ MILLION)
  • EXHIBIT 64 APAC THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 65 APAC THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
  • EXHIBIT 66 HISTORICAL DATA OF CONTACT LENSES USAGE IN APAC 2018-2020 ($ MILLION)
  • EXHIBIT 67 APAC THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 68 INCREMENTAL GROWTH BY APAC 2021 & 2027
  • EXHIBIT 69 JAPAN THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 70 CHINA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 71 INDIA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 72 SOUTH KOREA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 73 AUSTRALIA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 74 EUROPE THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 75 EUROPE THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 76 HISTORICAL DATA OF CONTACT LENSES USAGE IN EUROPE 2018-2020 ($ MILLION)
  • EXHIBIT 77 EUROPE THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 78 INCREMENTAL GROWTH BY EUROPE 2021 & 2027
  • EXHIBIT 79 GERMANY THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 80 FRANCE THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 81 UK THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 82 SPAIN THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 83 ITALY THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 84 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 85 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
  • EXHIBIT 86 LATIN AMERICA CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 87 INCREMENTAL GROWTH BY LATIN AMERICA 2021 & 2027
  • EXHIBIT 88 BRAZIL THERAPEUTIC CONTACT LENSES MARKET IN COUNTRY 2021-2027 ($ MILLION)
  • EXHIBIT 89 MEXICO THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 90 ARGENTINA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 91 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 92 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET: KEY COUNTRIES
  • EXHIBIT 93 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 94 INCREMENTAL GROWTH BY MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 95 TURKEY THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 96 SOUTH AFRICA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 97 SAUDI ARABIA THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 98 UAE THERAPEUTIC CONTACT LENSES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 99 PURE & DIVERSIFIED VENDORS IN GLOBAL THERAPEUTIC CONTACT LENSES MARKET
  • EXHIBIT 100 VENDORS OFFERING COMMERCIAL THERAPEUTIC CONTACT LENSES: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 101 VENDORS OFFERING COMMERCIAL THERAPEUTIC CONTACT LENSES: CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 102 ALCON: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 103 ALCON: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 104 ALCON: REVENUE BY BUSINESS SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 105 ALCON: REVENUE BY GEOGRAPHY 2019-2021 ($ MILLION)
  • EXHIBIT 106 BAUSCH & LOMB: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 107 JOHNSON & JOHNSON: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 108 JOHNSON & JOHNSON: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 109 JOHNSON & JOHNSON: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLION)
  • EXHIBIT 110 JOHNSON & JOHNSON: MAJOR PRODUCT OFFERINGS
  • EXHIBIT 111 THE COOPER COMPANIES: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 112 THE COOPER COMPANIES: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 113 THE COOPER COMPANIES: REVENUE BY BUSINESS SEGMENT 2019-2021 ($ MILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 RECENT HI-TECH CONTACT LENSES
  • TABLE 4 GLOBAL AGE COMPOSITION (2020)
  • TABLE 5 ADVANTAGES & DISADVANTAGES OF HYDROGEL CONTACT LENSES
  • TABLE 6 SOFT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 7 SOFT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 8 RIGID THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 9 RIGID THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 10 DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 11 DAILY REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 12 FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 13 FREQUENT REPLACEMENT THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 14 POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 15 POST OCULAR SURGERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 16 CORNEAL SURGERY/DISORDER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 17 CORNEAL SURGERY/DISORDER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 18 ADVANTAGES & DISADVANTAGES OF MAIN METHODOLOGIES USED PREPARE DRUG-LOADED CONTACT LENSES
  • TABLE 19 DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 20 DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 21 OTHER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 22 OTHER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 23 OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 24 OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 25 HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 26 HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 27 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 28 NORTH AMERICA CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 29 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 30 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 31 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 32 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 33 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 34 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 35 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 36 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 37 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 38 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 39 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 40 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 41 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 42 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 43 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 44 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 45 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 46 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 47 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 48 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 49 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 50 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 51 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 52 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 53 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 54 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 55 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 56 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 57 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 58 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 59 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 60 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 61 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 62 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 63 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 64 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 65 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 66 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 67 ALCON: MAJOR PRODUCT OFFERINGS
  • TABLE 68 BAUSCH & LOMB MAJOR PRODUCT OFFERINGS
  • TABLE 69 THE COOPER COMPANIES: MAJOR PRODUCT OFFERINGS
  • TABLE 70 ABB OPTICAL GROUP: MAJOR PRODUCT OFFERINGS
  • TABLE 71 ACCULENS: MAJOR PRODUCT OFFERINGS
  • TABLE 72 ADVANCED VISION TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 73 CONTAMAC: MAJOR PRODUCT OFFERINGS
  • TABLE 74 EXCELLENT HI-CARE: MAJOR PRODUCT OFFERINGS
  • TABLE 75 MEDENNIUM: MAJOR PRODUCT OFFERINGS
  • TABLE 76 MENICON: MAJOR PRODUCT OFFERINGS
  • TABLE 77 METRO OPTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 78 ORION VISION GROUP: MAJOR PRODUCT OFFERINGS
  • TABLE 79 POLYTOUCH: MAJOR PRODUCT OFFERINGS
  • TABLE 80 ST. SHINE OPTICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 81 SURGITECH INNOVATION: MAJOR PRODUCT OFFERINGS
  • TABLE 82 SYNERGEYES: MAJOR PRODUCT OFFERINGS
  • TABLE 83 ULTRAVISION CLPL: MAJOR PRODUCT OFFERINGS
  • TABLE 84 WALMAN: MAJOR PRODUCT OFFERINGS
  • TABLE 85 VISIONARY OPTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 86 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 87 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 88 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 89 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 90 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 91 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 92 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 93 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 94 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 95 GLOBAL THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 96 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 97 NORTH AMERICA CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 98 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 99 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 100 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 101 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 102 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 103 NORTH AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 104 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 105 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 106 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 107 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 108 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 109 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 110 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 111 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 112 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 113 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 114 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 115 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 116 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 117 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 118 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 119 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 120 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 121 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 122 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 123 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 124 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 125 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 126 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 127 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
  • TABLE 128 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 ($ MILLION)
  • TABLE 129 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL 2021-2027 (%)
  • TABLE 130 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027 ($ MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE 2021-2027(%)
  • TABLE 132 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 ($ MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION 2021-2027 (%)
  • TABLE 134 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
  • TABLE 135 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
目次
Product Code: ARZ221222

The global therapeutic contact lenses market is expected to grow at a CAGR of 4.90% from 2021-2027

MARKET INSIGHTS

  • Therapeutic contact lenses (TCLs) are mainly used for corneal diseases, and the clinical use of TCL after ophthalmic surgery usually focuses on corneal lesions, corneal refractive surgery, and corneal transplantation. These bandages were also used in cataract surgery. It also stimulates corneal metabolism, improves corneal regeneration, increases epithelial adhesion, maintains hydration, reduces collagenase accumulation, reduces edema, improves corneal clarity and vision, and is a vehicle for ophthalmic drug delivery.
  • The two most common contact lens variants available in the therapeutic contact lenses market include hard and soft contact lenses. RGP contact lenses are the most common type of hard contact lenses available in the industry. These lenses are usually made from plastic materials. These lenses hold their shape firmly and allow oxygen to flow through the wearer's eye lens. RGP lenses are helpful for people with astigmatism and keratoconus as they enable sharper vision when the cornea is unevenly curved compared to soft contact lenses. Soft contact lenses are made up of hydrogel and silicone hydrogel materials.
  • Nearly 125 million people worldwide wear contact lenses to correct regular or common vision problems, such as myopia, hyperopia, presbyopia, and astigmatism. This vision correction can be done per the user's needs without disturbing the physical appearance. By 2050, more than 2 billion people will be aged over 60. There is an increase in the global target population with the number of people requiring vision corrections. For instance, around 153 million people are affected by uncorrected refractive errors, 1.7 billion have presbyopia, 352 million people suffer from dry eyes, and 20 million people are facing blind from cataracts. In addition, the diabetic population does suffer from various vision-related issues. For instance, around 93 million people suffer from diabetic retinopathy, and more than 67 million suffer from glaucoma.

IMPACT OF COVID-19

The COVID-19 pandemic has largely affected customer behavior regarding therapeutic contact lenses. A considerable rise in first-time contact lens users has recently been witnessed. However, there has been an increase in the market's percentage of contact lens dropouts. Some first-time contact lens users include medical professionals, management professionals, and office workers who use computers and electronic devices for long hours daily. The common goal of these contact lens users was to eliminate the dependency on spectacle corrections while performing critical tasks. Simultaneously, in 2020, there was an increase in dropouts among long-term contact lens users in the therapeutic contact lenses market. Some reasons for a decline or complete discontinuation in contact lenses include concerns associated with the high risk of contracting infections, worsened dry eye conditions, and low demand for contact lenses due to remote work options from the comfort of homes.

MARKET TRENDS & DRIVERS

Increasing Use of Silicone Hydrogel Contact Lenses

Silicone hydrogel contact lenses have become the most widely used contact lenses. As they are easy and handy to use with no maintenance required, they do not cause any harm to people compared to extended wearable lenses. Also, Silicone hydrogel lenses can treat eye problems such as red eyes, blurred vision, corneal swelling, and general discomfort in the eyes. Many key players in the therapeutic contact lenses market do offer Silicone hydrogel therapeutic contact lenses, such as Acuvue Oasys (Johnson & Johnson Vision Care), Air Optix Aqua (Alcon), Biofinity (CooperVision), and PureVision2 (Bausch & Lomb).

The Coming Rise of Drug-delivery Contact Lenses

Extensive research has been documented recognizing the potential of BCL as a drug delivery system. This is due to their superior drug bioavailability compared to eye drops and their ability to be used on long-wearing schedules, increasing dosing frequency, side effects, and compliance. Desired properties of drug delivery devices include easy, comfortable, and controlled administration over an extended period with preservation of vision and ocular function.

Introduction of Hi-Tech Contact Lenses

Hi-tech contact lenses are used to treat eye disorders and more. The hi-tech contact lenses involve various processes, such as delivering the drug to the eye, providing augmented reality, monitoring eye health conditions, and more. Mojo Vision, a California-based company working on AR (Augmented Reality) based smart contact lenses, has launched contact lenses that elevate users' vision. These lenses are equipped with an inbuilt display that provides timely information regarding the objects focused on without interrupting the real vision.

Growing Prevalence of Ophthalmic Disorders & Geriatric Population

As populations continue to expand, so does the need for eye care. Aging is one of the most significant global demographic factors impacting eye care as the need for vision correction increases and becomes more complex as a person grows older. In 2018, around one-third of the global population was above the age of 45, the average onset of presbyopia (long-sightedness caused by loss of elasticity of the eye's lens).

Further, the rise in urbanization and the expansion of middle classes in fast-developing markets, particularly in Latin America and Asia, have transformed the economy and local eye health requirements. A considerable increase in migration from rural areas to cities in search of better jobs has contributed to the demand for better healthcare requirements and trends. Increased disposable incomes are encouraging people to prefer the luxury products like contact lenses in the market, which is one of the major factors contributing to the growth of the global therapeutic contact lenses market.

Technological Advancements in Contact Lenses

The key vendors in the contact lenses market are constantly investing in research & development to launch a new variety of contact lenses benefitting the market's users and fulfilling the market's unmet needs. New products are one of the unique strategies to drive customers towards new products with unique features in the therapeutic contact lenses market. In 2019, Bausch & Lomb launched the ULTRA multifocal toric contact lens for presbyopia patients. The ULTRA multifocal for astigmatism features vision at all distances and a stable fit for consistent results.

Public and Private Initiatives to Increase Vision Care Awareness

Favorable initiatives of governments around the world to promote advanced vision aids will support therapeutic contact lenses market growth in the coming years. For example, the US Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) is actively working to raise awareness of behaviors and risk factors that affect vision in contact lens wearers through the Vision Health Initiative. In addition to government and public health organizations, many private organizations worldwide are actively involved in advancing ophthalmology. For example, in 2018, Johnson & Johnson Vision launched a global campaign called SpotlightSight in honor of World Sight Day.

SEGMENTATION ANALYSIS

INSIGHTS BY MATERIAL

The global therapeutic contact lenses market is segmented into soft and rigid contact lenses by material segment. Among the material segment, the soft contact lenses segment dominates the market with a share of 85.25%, followed by rigid contact lenses in 2021. The soft contact lenses segment will likely witness the highest CAGR of 5.03%, with incremental growth of USD 932.18 million. Hydrogels used to manufacture therapeutic soft contact lenses are commonly synthesized by free radical and UV photopolymerization and cast molding. The main network of hydrogels that make up soft contact lenses is usually based on poly(hydroxyethyl methacrylate) (HEMA), especially methafilcon A. Soft hydrogel contact lenses are typically more comfortable to wear than rigid or hard lenses, as they are more flexible and move and bend with the eyes.

Segmentation by Material

  • Soft Contact Lenses
  • Rigid Contact Lenses

INSIGHTS BY USAGE

The daily replacement segment dominated the global therapeutic contact lenses market, with a share of 55.24% in 2021, and is likely to witness the highest CAGR of 5.16%. Daily replacement contact lenses are one-time usable lenses that are discarded post-usage. One of the major reasons for the preference is its ease of use, reduced infections, and more comfort on the eye. This has largely driven the usage of daily disposable contact lenses in the market. Daily disposable contact lenses are increasing among specialists and are also largely recommended among users. Further, the adoption of daily contact lenses is high among developed countries, whereas among developing countries, the usage of daily disposable contact lenses is low in the market.

Segmentation by Usage

  • Daily Disposable
  • Frequently Replacement

INSIGHTS BY APPLICATION

  • The post-ocular surgery segment dominated the global therapeutic contact lenses market with a share of 35.77%. The use of therapeutic lenses is safe and effective in protecting the ocular surface and stabilizing the tear film after cataract surgery, has the advantage of preserving the 'immediate vision' of the operated eye, and is a promising alternative to covering the eye patch coverage in the postoperative management of cataracts surgical patients, especially those with monovision.
  • However, the corneal surgery/disorder segment will likely witness the highest incremental growth of USD 345.57 million over the forecast period. Therapeutic contact lenses are important for treating ocular surface and corneal disorders. A therapeutic contact lens or bandage lens is a contact lens that protects and heals the cornea. Further, the increasing number of corneal surgeries drives the demand for therapeutic lenses. Corneal surgery/transplantation is currently the world's most widely performed tissue transplant procedure.

Segmentation By Application

  • Post Ocular Surgery
  • Corneal Surgery/Disorder
  • Drug Delivery
  • Others

INSIGHTS BY DISTRIBUTION CHANNEL

The Omni channel distribution dominates the therapeutic contact lenses market with a share of 73.31%. It is likely to witness incremental growth of USD 864.79 million. The Omni channels comprise retail and online stores. Compared to developed countries, such as Latin America and Asia, distribution through retail stores has increased in developing countries. The reputation, consumer awareness about the brands, and customer satisfaction have increased loyalty, still driving them to prefer retail stores to purchase contact lenses in the market. In addition, multiple commercial campaigns are launched by various retail stores, which attracts users to move towards retail stores.

Segmentation By Distribution Channel

  • Omni Channel
  • Hospitals & Eye Care Clinics

GEOGRAPHICAL ANALYSIS

In 2021, North America dominated the global therapeutic contact lenses market with a share of 34.68%. The region is one of the major consumers of contact lenses due to people's increased awareness and disposable income. This makes the companies largely focus on launching their products in the market. Countries like the US and Canada have well-developed healthcare systems and a stringent regulatory environment for manufacturers of contact lenses. Also, market vendors are investing in R&D initiatives and advanced technologies to develop efficient contact lens products.

APAC is expected to witness the highest CAGR growth of 5.30% in the global therapeutic contact lenses market over the forecast period. In 2020, APAC had a higher number of customers using contact lenses in the countries such as China, India, and more. In addition, the surge in the target population is majorly driving the demand for contact lenses. The growing myopic population in the region, including teenagers, and elderly individuals, is one of the driving factors. In addition, increasing awareness regarding brand consciousness is accelerating the demand for contact lenses in the region.

Segmentation by Geography

  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • UAE

VENDOR LANDSCAPE

The global therapeutic contact lenses market is highly consolidated, with the key players including Alcon, Bausch & Lomb, Johnson & Johnson, and The Cooper Companies accounting for a major market share. The market is subjected to constant technological advances and regularly evolving vision correction requirements and standards. Vendors compete based on product variety, pricing, quality, technological leadership and innovation, and the efficacy of therapeutic contact lenses.

Key Developments in The Global Therapeutic Contact Lenses Market

  • Alcon brands such as Dailies and Air Optix have enabled the company to achieve a significant therapeutic contact lens market share. In 2016, Alcon launched Air Optix plus HydraGlyde in the US and the EU, an innovative upgrade to monthly SiHy contact lenses featuring the HydraGlyde moisture matrix technology for long-lasting lens surface wettability and another product, DAILIES TOTAL1 Multifocal contact lenses in both the US and the EU.
  • Johnson & Johnson's growth is primarily driven by its daily disposable lens sales in the ACUVUE OASYS contact lenses category. In 2021, Johnson & Johnson Vision received approval in Canada for ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management.

Key Vendors

  • Alcon
  • Bausch & Lomb
  • Johnson & Johnson
  • The Cooper Companies

Other Prominent Vendors

  • ABB Optical Group
  • AccuLens
  • Advanced Vision Technologies
  • Contamac
  • Excellent Hi-Care
  • Medennium
  • Menicon
  • Metro Optics
  • Orion Vision Group
  • POLYTOUCH
  • Shine Optical
  • SURGITECH INNOVATION
  • SynergEyes
  • UltraVision CLPL
  • Walman
  • Visionary Optics

KEY QUESTIONS ANSWERED

  • 1. What is the size of the therapeutic contact lenses market?
  • 2. What is the growth rate of the therapeutic contact lenses market?
  • 3. Who are the key players in the global therapeutic contact lenses market?
  • 4. Which region has the highest global therapeutic contact lenses market share?
  • 5. What factors impact the growth of the therapeutic contact lenses market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY MATERIAL
    • 4.3.2 MARKET SEGMENTATION BY USAGE
    • 4.3.3 MARKET SEGMENTATION BY APPLICATION
    • 4.3.4 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
    • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

  • 7.1 OVERVIEW

8 INTRODUCTION

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 INCREASE IN SILICONE HYDROGEL CONTACT LENSES APPLICATION
  • 9.2 ADVANCES IN DRUG-DELIVERY CONTACT LENSES TECHNOLOGY
  • 9.3 INTRODUCTION OF HI-TECH CONTACT LENSES

10 MARKET GROWTH ENABLERS

  • 10.1 GROWING PREVALENCE OF OPHTHALMIC DISORDERS & GERIATRIC POPULATION
  • 10.2 ADVANCES IN CONTACT LENSES TECHNOLOGY
  • 10.3 PUBLIC AND PRIVATE INITIATIVES TO INCREASE VISION CARE AWARENESS

11 MARKET RESTRAINTS

  • 11.1 HIGH COST OF THERAPEUTIC CONTACT LENSES
  • 11.2 ADVERSE EVENTS ASSOCIATED WITH CONTACT LENSES
  • 11.3 LOW ACCESSIBILITY, AFFORDABILITY, & FINANCIAL EXCLUSION FOR LARGE PATIENT POOL

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 GEOGRAPHY INSIGHTS
    • 12.2.2 MATERIAL SEGMENTATION INSIGHTS
    • 12.2.3 USAGE SEGMENTATION INSIGHTS
    • 12.2.4 APPLICATIONS SEGMENTATION INSIGHTS
    • 12.2.5 DISTRIBUTION CHANNEL SEGMENTATION INSIGHTS
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 MATERIAL

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 SOFT CONTACT LENSES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 SOFT CONTACT LENSES MARKET BY GEOGRAPHY
  • 13.4 RIGID CONTACT LENSES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 RIGID CONTACT LENSES MARKET BY GEOGRAPHY

14 USAGE

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 DAILY REPLACEMENT
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 DAILY REPLACEMENT MARKET BY GEOGRAPHY
  • 14.4 FREQUENT REPLACEMENT
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 FREQUENT REPLACEMENT MARKET BY GEOGRAPHY

15 APPLICATION

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 POST OCULAR SURGERY
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 POST OCULAR SURGERY MARKET BY GEOGRAPHY
  • 15.4 CORNEAL SURGERY/DISORDER
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 CORNEAL SURGERY/DISORDER MARKET BY GEOGRAPHY
  • 15.5 DRUG DELIVERY
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 DRUG DELIVERY THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY
  • 15.6 OTHERS
    • 15.6.1 MARKET OVERVIEW
    • 15.6.2 MARKET SIZE & FORECAST
    • 15.6.3 OTHER THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY

16 DISTRIBUTION CHANNEL

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 OMNI CHANNEL
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
    • 16.3.3 OMNI CHANNEL THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY
  • 16.4 HOSPITALS & EYE CARE CLINICS
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
    • 16.4.3 HOSPITALS & EYE CARE CLINICS THERAPEUTIC CONTACT LENSES MARKET BY GEOGRAPHY

17 GEOGRAPHY

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 NORTH AMERICA MARKET BY MATERIAL
    • 18.2.2 NORTH AMERICA MARKET BY USAGE
    • 18.2.3 NORTH AMERICA MARKET BY APPLICATION
    • 18.2.4 NORTH AMERICA MARKET BY DISTRIBUTION CHANNEL
  • 18.3 KEY COUNTRIES
    • 18.3.1 US: MARKET SIZE & FORECAST
    • 18.3.2 CANADA: MARKET SIZE & FORECAST

19 APAC

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 APAC THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
    • 19.2.2 APAC THERAPEUTIC CONTACT LENSES MARKET BY USAGE
    • 19.2.3 APAC THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
    • 19.2.4 APAC THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
  • 19.3 KEY COUNTRIES
    • 19.3.1 JAPAN: MARKET SIZE & FORECAST
    • 19.3.2 CHINA: MARKET SIZE & FORECAST
    • 19.3.3 INDIA: MARKET SIZE & FORECAST
    • 19.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 19.3.5 AUSTRALIA: MARKET SIZE & FORECAST

20 EUROPE

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
    • 20.2.2 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY USAGE
    • 20.2.3 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
    • 20.2.4 EUROPE THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
  • 20.3 KEY COUNTRIES
    • 20.3.1 GERMANY: MARKET SIZE & FORECAST
    • 20.3.2 FRANCE: MARKET SIZE & FORECAST
    • 20.3.3 UK: MARKET SIZE & FORECAST
    • 20.3.4 SPAIN: MARKET SIZE & FORECAST
    • 20.3.5 ITALY: MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
    • 21.2.1 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
    • 21.2.2 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE
    • 21.2.3 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
    • 21.2.4 LATIN AMERICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
  • 21.3 KEY COUNTRIES
    • 21.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 21.3.2 MEXICO: MARKET SIZE & FORECAST
    • 21.3.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
    • 22.2.1 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY MATERIAL
    • 22.2.2 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY USAGE
    • 22.2.3 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY APPLICATION
    • 22.2.4 MIDDLE EAST & AFRICA THERAPEUTIC CONTACT LENSES MARKET BY DISTRIBUTION CHANNEL
  • 22.3 KEY COUNTRIES
    • 22.3.1 TURKEY: MARKET SIZE & FORECAST
    • 22.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
    • 22.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 22.3.4 UAE: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

  • 23.1 COMPETITION OVERVIEW
  • 23.2 MARKET SHARE ANALYSIS
    • 23.2.1 ALCON
    • 23.2.2 BAUSCH & LOMB
    • 23.2.3 JOHNSON & JOHNSON
    • 23.2.4 THE COOPER COMPANIES

24 KEY COMPANY PROFILES

  • 24.1 ALCON
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 PRODUCT OFFERINGS
    • 24.1.3 KEY STRATEGIES
    • 24.1.4 KEY STRENGTHS
    • 24.1.5 KEY OPPORTUNITIES
  • 24.2 BAUSCH & LOMB
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
    • 24.2.3 KEY STRATEGIES
    • 24.2.4 KEY STRENGTHS
    • 24.2.5 KEY OPPORTUNITIES
  • 24.3 JOHNSON & JOHNSON
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 PRODUCT OFFERINGS
    • 24.3.3 KEY STRATEGIES
    • 24.3.4 KEY STRENGTHS
    • 24.3.5 KEY OPPORTUNITIES
  • 24.4 THE COOPER COMPANIES
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 PRODUCT OFFERING
    • 24.4.3 KEY STRATEGIES
    • 24.4.4 KEY STRENGTHS
    • 24.4.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

  • 25.1 ABB OPTICAL GROUP
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 PRODUCT OFFERINGS
  • 25.2 ACCULENS
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 PRODUCT OFFERINGS
  • 25.3 ADVANCED VISION TECHNOLOGIES
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 PRODUCT OFFERINGS
  • 25.4 CONTAMAC
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 PRODUCT OFFERINGS
  • 25.5 EXCELLENT HI-CARE
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 PRODUCT OFFERINGS
  • 25.6 MEDENNIUM
    • 25.6.1 BUSINESS OVERVIEW
    • 25.6.2 PRODUCT OFFERINGS
  • 25.7 MENICON
    • 25.7.1 BUSINESS OVERVIEW
    • 25.7.2 PRODUCT OFFERINGS
  • 25.8 METRO OPTICS
    • 25.8.1 BUSINESS OVERVIEW
    • 25.8.2 PRODUCT OFFERINGS
  • 25.9 ORION VISION GROUP
    • 25.9.1 BUSINESS OVERVIEW
    • 25.9.2 PRODUCT OFFERINGS
  • 25.10 POLYTOUCH
    • 25.10.1 BUSINESS OVERVIEW
    • 25.10.2 PRODUCT OFFERINGS
  • 25.11 ST. SHINE OPTICAL
    • 25.11.1 BUSINESS OVERVIEW
    • 25.11.2 PRODUCT OFFERINGS
  • 25.12 SURGITECH INNOVATION
    • 25.12.1 BUSINESS OVERVIEW
    • 25.12.2 PRODUCT OFFERINGS
  • 25.13 SYNEREYES
    • 25.13.1 BUSINESS OVERVIEW
    • 25.13.2 PRODUCT OFFERINGS
  • 25.14 ULTRAVISION CLPL
    • 25.14.1 BUSINESS OVERVIEW
    • 25.14.2 PRODUCT OFFERINGS
  • 25.15 WALMAN
    • 25.15.1 BUSINESS OVERVIEW
    • 25.15.2 PRODUCT OFFERINGS
  • 25.16 VISIONARY OPTICS
    • 25.16.1 BUSINESS OVERVIEW
    • 25.16.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

  • 26.1 KEY TAKEAWAYS
  • 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

  • 27.1 MARKET BY GEOGRAPHY
  • 27.2 MARKET BY MATERIAL
  • 27.3 MARKET BY USAGE
  • 27.4 MARKET BY APPLICATION
  • 27.5 MARKET BY DISTRIBUTION CHANNEL
  • 27.6 NORTH AMERICA: BY MATERIAL
  • 27.7 NORTH AMERICA: BY USAGE
  • 27.8 NORTH AMERICA: BY APPLICATION
  • 27.9 NORTH AMERICA: BY DISTRIBUTION CHANNEL
  • 27.1 APAC: BY MATERIAL
  • 27.11 APAC: BY USAGE
  • 27.12 APAC: BY APPLICATION
  • 27.13 APAC: BY DISTRIBUTION CHANNEL
  • 27.14 EUROPE: BY MATERIAL
  • 27.15 EUROPE: BY USAGE
  • 27.16 EUROPE: BY APPLICATION
  • 27.17 EUROPE: BY DISTRIBUTION CHANNEL
  • 27.18 LATIN AMERICA: BY MATERIAL
  • 27.19 LATIN AMERICA: BY USAGE
  • 27.2 LATIN AMERICA: BY APPLICATION
  • 27.21 LATIN AMERICA: BY DISTRIBUTION CHANNEL
  • 27.22 MIDDLE EAST & AFRICA: BY MATERIAL
  • 27.23 MIDDLE EAST & AFRICA: BY USAGE
  • 27.24 MIDDLE EAST & AFRICA: BY APPLICATION
  • 27.25 MIDDLE EAST & AFRICA: BY DISTRIBUTION CHANNEL

28 APPENDIX

  • 28.1 ABBREVIATIONS